Hyperion Asset Management Ltd Grows Stake in Intuitive Surgical, Inc. $ISRG

Hyperion Asset Management Ltd boosted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 49.8% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 419,329 shares of the medical equipment provider’s stock after acquiring an additional 139,422 shares during the quarter. Intuitive Surgical comprises about 4.4% of Hyperion Asset Management Ltd’s holdings, making the stock its 11th largest holding. Hyperion Asset Management Ltd owned approximately 0.12% of Intuitive Surgical worth $166,759,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Laurel Wealth Advisors LLC acquired a new stake in Intuitive Surgical during the 4th quarter valued at $31,000. Turning Point Benefit Group Inc. increased its stake in Intuitive Surgical by 833.3% during the 4th quarter. Turning Point Benefit Group Inc. now owns 56 shares of the medical equipment provider’s stock worth $32,000 after buying an additional 50 shares during the period. Motiv8 Investments LLC acquired a new position in Intuitive Surgical in the 4th quarter worth $34,000. Oakworth Capital Inc. boosted its position in Intuitive Surgical by 281.2% in the 4th quarter. Oakworth Capital Inc. now owns 61 shares of the medical equipment provider’s stock valued at $35,000 after buying an additional 45 shares during the last quarter. Finally, Main Street Group LTD purchased a new position in Intuitive Surgical in the 1st quarter valued at about $30,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In other news, EVP Gary Loeb sold 400 shares of the business’s stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $379.00, for a total value of $151,600.00. Following the completion of the sale, the executive vice president directly owned 5,320 shares in the company, valued at approximately $2,016,280. The trade was a 6.99% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy L. Ladd sold 400 shares of the company’s stock in a transaction that occurred on Monday, August 10th. The shares were sold at an average price of $379.00, for a total value of $151,600.00. Following the sale, the director directly owned 251 shares in the company, valued at approximately $95,129. This represents a 61.44% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 7,106 shares of company stock worth $2,949,518. 0.60% of the stock is currently owned by corporate insiders.

Trending Headlines about Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Intuitive Surgical’s second-quarter results exceeded expectations: revenue rose 18.4% year over year to $2.89 billion, while EPS reached $2.80 versus the $2.48 consensus estimate. Higher margins, continued adoption of its da Vinci and Ion platforms, and long-term demand for robotic-assisted surgery support the bullish case. Intuitive Surgical Just Beat Earnings
• Positive Sentiment: A bullish investor cited Intuitive Surgical’s potential once-per-decade hardware replacement cycle and approximately $8.6 billion cash position, arguing that the more than 30% year-to-date decline could create an attractive long-term entry point. The Number One Reason I Keep Buying Intuitive Surgical
• Neutral Sentiment: Analyst sentiment remains broadly favorable, with a “Moderate Buy” consensus and an average price target of $509.02. However, several firms recently lowered their targets, reflecting greater caution after the earnings report.
• Neutral Sentiment: Reported short interest was zero shares, implying no measurable short-selling pressure. The figure appears unusual and may reflect incomplete or unreliable data rather than a meaningful market signal.
• Negative Sentiment: Despite the earnings beat, investors remain concerned about slowing domestic procedure growth and whether the company’s roughly 46 P/E adequately reflects its growth prospects. Those concerns have contributed to the stock’s recent weakness. Intuitive Surgical Earnings and Valuation Analysis
• Negative Sentiment: Director Amy L. Ladd sold 472 shares across August 10–11, reducing her holdings by a substantial percentage, while EVP Gary Loeb sold 400 shares. Both transactions were made under pre-arranged Rule 10b5-1 plans, which reduces their significance as a discretionary bearish signal but may still weigh modestly on sentiment.

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock opened at $401.23 on Wednesday. The firm has a market cap of $141.75 billion, a PE ratio of 45.96, a price-to-earnings-growth ratio of 2.84 and a beta of 1.46. Intuitive Surgical, Inc. has a 1 year low of $328.57 and a 1 year high of $603.88. The firm’s 50-day simple moving average is $392.47 and its 200-day simple moving average is $443.35.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share for the quarter, beating the consensus estimate of $2.48 by $0.32. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%.The firm had revenue of $2.89 billion during the quarter, compared to analyst estimates of $2.83 billion. During the same period in the previous year, the company earned $1.81 earnings per share. Intuitive Surgical’s quarterly revenue was up 18.4% on a year-over-year basis. On average, equities analysts predict that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current year.

Analysts Set New Price Targets

ISRG has been the topic of a number of analyst reports. Leerink Partners dropped their target price on Intuitive Surgical from $573.00 to $454.00 and set an “outperform” rating on the stock in a research report on Friday, July 17th. The Goldman Sachs Group set a $558.00 price target on Intuitive Surgical in a report on Wednesday, May 27th. Weiss Ratings restated a “hold (c)” rating on shares of Intuitive Surgical in a report on Tuesday, May 19th. Piper Sandler set a $357.44 target price on Intuitive Surgical in a research report on Monday, July 27th. Finally, Bank of America reduced their target price on Intuitive Surgical from $520.00 to $515.00 in a research note on Friday, June 12th. Twenty equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $509.02.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.